We have evaluated the anti-inflammatory activity of the sodium salt of 4-(0-β-D-glucopyranosyloxy)benzoic acid in comparison to well-known nonsteroidal anti-inflammatory drugs (NSAIDs). Carragcenan suspension (1%, 0.1 mL) was injected into subplantar region of the right hindpaw of rats (n - 12) pretreated (7 days and 60 min before carrageenan injection) intragastrically with methyl ester of 4(β-D-glucopyranosyloxy)benzoic acid (20 mg/kg), acetylsalicylic acid (20 mg/kg), 4-hydroxy benzoic acid (20 mg/kg), or vehicle (2 mL of purified water). Paw edema volume was measured plethysmographically at 1,2 and 4 h after carrageenan injection. The results showed that intragastric administration of the sodium salt of 4-(0-β-D-glucopyranosyIoxy)benzoic acid in a dose of 20 mg/kg for 7 days decreased the intensity of experimental inflammation.
|Number of pages||3|
|Journal||Eksperimental'naya i Klinicheskaya Farmakologiya|
|Publication status||Published - 1 Jan 2016|
- Innovative drug
- Phenol glycoside
ASJC Scopus subject areas